Loading stock data...

Krsnaa Diagnostics Limited

NSE: KRSNAA BSE: KRSNAA

NSE
638.00 10.55 (1.68%)

Prev Close

627.45

Open Price

644

Volume

62,016

Today Low / High

621 / 644

52 WK Low / High

621 / 894.4

Range

606 - 670

BSE
633.70 5.50 (0.88%)

Prev Close

628.2

Open Price

628.3

Volume

943

Today Low / High

621.3 / 634.05

52 WK Low / High

621.3 / 891.8

Range

602 - 665

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 638 (target range: 606 - 670), reflecting a change of 10.55 (1.68141%). On the BSE, it is listed at 633.7 (target range: 602 - 665), showing a change of 5.5 (0.87552%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

25 Feb 644.00 -2.21%
24 Feb 640.00 -1.96%
23 Feb 645.00 -1.10%
20 Feb 646.00 -0.60%
19 Feb 664.50 -2.30%
18 Feb 670.55 -0.96%
17 Feb 660.20 1.57%
16 Feb 671.25 -1.09%
13 Feb 673.55 -0.73%
12 Feb 678.40 -0.55%
11 Feb 707.45 -4.12%
10 Feb 703.15 -0.41%
09 Feb 700.80 -0.19%
06 Feb 685.00 2.31%
05 Feb 726.95 -0.86%
04 Feb 718.20 1.18%
03 Feb 713.95 0.60%
02 Feb 695.35 0.03%
01 Feb 718.00 -3.15%
30 Jan 705.10 0.99%
29 Jan 712.00 -1.26%
28 Jan 713.15 0.50%

Krsnaa Diagnostics Limited Graph

Krsnaa Diagnostics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Krsnaa Diagnostics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 638.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 633.70 640.04 576.03 - 704.04
646.37 517.10 - 775.65
652.71 456.90 - 848.52
Bearish Scenario 633.70 627.36 564.63 - 690.10
621.03 496.82 - 745.23
614.69 430.28 - 799.10

Overview of Krsnaa Diagnostics Limited

ISIN

INE08LI01020

Industry

Medical - Diagnostics & Research

Vol.Avg

64,490

Market Cap

20,695,872,736

Last Dividend

2.75

Official Website

Visit Website

IPO Date

2021-08-16

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of KRSNAA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-12 September 12, 25 2.75 2.75 2025-09-12 2025-10-25
2024-09-13 September 13, 24 2.5 2.5 2024-09-13 2024-10-21
2023-09-15 September 15, 23 2.75 2.75
2022-09-15 September 15, 22 2.5 2.5

Stock Rating Details for KRSNAA

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 717.16 Cr 169.26 Cr 547.90 Cr 0.7640 0.00 Cr 60.68 Cr 103.47 Cr 77.61 Cr 24.04 215.66 Cr 0.1082
2024-03-31 619.63 Cr 414.98 Cr 204.65 Cr 0.3303 0.00 Cr 10.07 Cr 71.19 Cr 56.84 Cr 17.90 161.04 Cr 0.0917
2023-03-31 487.12 Cr 74.18 Cr 412.94 Cr 0.8477 0.00 Cr 8.15 Cr 70.26 Cr 62.11 Cr 19.78 141.68 Cr 0.1275
2022-03-31 455.45 Cr 60.30 Cr 395.15 Cr 0.8676 0.00 Cr 6.44 Cr 90.90 Cr 68.39 Cr 22.89 146.39 Cr 0.1502
2021-03-31 396.46 Cr 83.75 Cr 312.71 Cr 0.7888 0.00 Cr 10.79 Cr 56.88 Cr 184.93 Cr 160.36 358.83 Cr 0.4665

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.85 Cr 1,281.60 Cr 398.83 Cr 882.7700 Cr 203.53 Cr 135.09 Cr 29.48 Cr 670.40 Cr 0.00 Cr 0.00 Cr 135.45 Cr 305.3880 Cr
2024-03-31 2.38 Cr 1,171.91 Cr 362.11 Cr 809.8020 Cr 159.79 Cr 157.41 Cr 35.81 Cr 690.93 Cr 0.11 Cr 36.38 Cr -18.22 Cr 281.4660 Cr
2023-03-31 22.72 Cr 909.89 Cr 171.16 Cr 738.7360 Cr 32.48 Cr 9.76 Cr 25.07 Cr 493.33 Cr 26.58 Cr 0.01 Cr 155.62 Cr 99.1940 Cr
2022-03-31 88.45 Cr 876.15 Cr 207.44 Cr 684.4090 Cr 40.99 Cr -53.47 Cr 9.17 Cr 411.64 Cr 0.17 Cr 0.13 Cr 115.52 Cr 121.0210 Cr
2021-03-31 24.68 Cr 604.53 Cr 372.67 Cr 231.8650 Cr 231.78 Cr 207.10 Cr 7.21 Cr 311.00 Cr 1.31 Cr 3.30 Cr 16.24 Cr 183.8050 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 87.3270 Cr -99.6090 Cr 13.7530 Cr -39.3000 Cr 1.4710 Cr 3.8460 Cr -126.6270 Cr 77.6080 Cr 58.8210 Cr -8.0720 Cr 6.3310 Cr
2024-03-31 24.3450 Cr -128.8770 Cr 84.1870 Cr -169.5420 Cr -20.3450 Cr 2.3750 Cr -193.8870 Cr 56.8370 Cr 90.2210 Cr -8.6290 Cr -10.7330 Cr
2023-03-31 76.3010 Cr -108.8890 Cr -33.1450 Cr -65.0590 Cr -65.7330 Cr 22.7200 Cr -141.3600 Cr 80.2010 Cr -9.1300 Cr -7.8490 Cr -15.9040 Cr
2022-03-31 128.4240 Cr -240.6360 Cr 175.9900 Cr -3.7950 Cr 63.7780 Cr 88.4530 Cr -132.2190 Cr 86.5100 Cr -189.3720 Cr 0.0000 Cr -1.9610 Cr
2021-03-31 102.5580 Cr -61.1390 Cr 30.8400 Cr 35.7180 Cr 72.2590 Cr 24.6750 Cr -66.8400 Cr 295.4520 Cr 55.5270 Cr 0.0000 Cr -2.1430 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 181.20 Cr 112.97 Cr 68.24 Cr 0.3766 23.79 Cr 15.25 Cr 4.70 50.21 Cr 0.0841
2025-09-30 205.99 Cr 65.14 Cr 140.85 Cr 0.6838 35.57 Cr 23.95 Cr 7.38 63.34 Cr 0.1162
2025-06-30 192.98 Cr 62.79 Cr 130.19 Cr 0.6746 29.76 Cr 20.52 Cr 6.35 55.35 Cr 0.1063
2025-03-31 186.08 Cr 41.55 Cr 144.53 Cr 0.7767 94.34 Cr 20.68 Cr 6.40 53.11 Cr 0.1111
2024-12-31 174.51 Cr 53.47 Cr 121.04 Cr 0.6936 22.37 Cr 19.42 Cr 6.01 54.31 Cr 0.1113

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 10.56 Cr 149.15 Cr 159.71 Cr 358.28 Cr 31.49 Cr 576.65 Cr 710.22 Cr 1,506.69 Cr 583.74 Cr
2025-06-30 0.00 Cr 0.00 Cr 68.44 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -882.77 Cr
2025-03-31 68.44 Cr 0.00 Cr 68.44 Cr 277.75 Cr 29.48 Cr 414.47 Cr 670.40 Cr 1,281.60 Cr 398.83 Cr
2024-12-31 0.00 Cr 0.00 Cr 62.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -840.76 Cr
2024-09-30 11.28 Cr 51.34 Cr 62.62 Cr 243.47 Cr 30.69 Cr 417.31 Cr 689.81 Cr 1,294.54 Cr 453.78 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 20.52 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 20.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 19.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 19.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 17.92 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Diagnostics & Research

Company Name Symbol Price Market Cap Volume
Dr. Lal PathLabs Limited LALPATHLAB ₹1,428.70 ₹238,555,002,304.00 ₹99,162.00
Sai Life Sciences Ltd. SAILIFE ₹925.00 ₹195,756,612,250.00 ₹562,918.00
Vijaya Diagnostic Centre Limited VIJAYA ₹990.50 ₹101,749,053,070.00 ₹65,450.00
Metropolis Healthcare Limited METROPOLIS ₹1,880.10 ₹97,449,155,190.00 ₹13,605.00

Key Executives

National Sales Head
Gaurav Sachdev

Gender: male

Year Born: 1986

Group Chief Executive Officer
Mitesh Dave

Gender: male

Year Born:

Chief Financial Officer
Pawan Daga

Gender: male

Year Born: 1985

Executive Chairman
Rajendra Khivraj Mutha

Gender: male

Year Born: 1974

Company Secretary & Compliance Officer
Sujoy Sudipta Bose

Gender: male

Year Born:

MD & Director
Yash Prithviraj Mutha

Gender: male

Year Born: 1981

Executive Director
Pallavi Shantilal Bhatevara

Gender: female

Year Born: 1978

Vice President
Dharmendra Kumar Madan Lal Sharma

Gender: Not Specified

Year Born:

FAQs about Krsnaa Diagnostics Limited

Who is the CEO of the company?

The CEO is Mitesh Dave.

What is the current market price of the stock?

The current price is ₹638.00.

What is the 52-week price range?

The range is ₹621-894.4.

What is the market capitalization of the company?

The market capitalization is ₹2,069.59 crores.

What is the dividend yield?

The dividend yield is 0.43%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 25.74.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Krsnaa Diagnostics Limited (ISIN: INE08LI01020) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹2,069.59 crores and an average daily volume of 64,490 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹2.75.